Figure 6. Western blot analysis of the tumor groups and the control group using anti- glycerol-3-phosphate dehydrogenase 1 (anti-GPD1) antibody (A) and anti-monoacylglycerol lipase (anti-MAGL) antibody (B) to determine the changes on the protein expression levels. The band intensities were measured by performing densitometric analysis using ImageJ software. Lum, Luminal; TNBC, triple-negative breast cancer.